NOTICE OF RESCHEDULING
In light of the continuing impact of the COVID-19 global pandemic, the Hippo 2021 Conference Organising Committee has made the difficult decision to reschedule the Hippo Signalling in Development, Disease and New Therapies Conference, originally scheduled for 17 – 20 November 2021, to 1 – 4 November 2022 in Singapore. Please visit this new conference website for updates. Please note that we will not convene an online Hippo conference in 2021.
Thank you for your kind understanding and we look forward to your participation at the in-person conference from 1 - 4 November 2022.
Thank you for your kind understanding and we look forward to your participation at the in-person conference from 1 - 4 November 2022.
General Information
|
Hippo Signalling in Development, Disease and New Therapies
New Dates: 1 - 4 November 2022 |
|
Organizing Committee
|
Wanjin HONG
Institute of Molecular and Cell Biology (IMCB), A*STAR Research Entities, Singapore Kieran HARVEY Peter MacCallum Cancer Centre, Australia |
Marius SUDOL
Icahn School of Medicine at Mount Sinai New York, USA |
Synopsis of Conference
The discovery and characterisation of signalling pathways has been essential for understanding organism development, as well as human diseases. The Hippo pathway is the last major signalling pathway to be discovered and is a key regulator of multiple biological processes including organ size, cell fate and stem cells. Furthermore, the Hippo pathway is deregulated in almost all human cancers and has been implicated in other human diseases. As such, the Hippo pathway is now a major focus of drug discovery programs for diseases such as cancer and cardiovascular disease.
We are pleased to invite you to attend the Hippo Signalling in Development, Disease and New Therapies Conference, which will be held from 1 - 4 November 2022 in Biopolis, Singapore.
This four-day scientific conference has assembled prominent Hippo researchers from around the world to discuss the latest insights into how this pathway controls development and disease, and how we can target it therapeutically in order to benefit patients with different diseases, most notably cancers. The Conference will provide a platform for valuable exchanges and a forum to foster new collaborations.
We look forward to welcoming you at the Conference.
We are pleased to invite you to attend the Hippo Signalling in Development, Disease and New Therapies Conference, which will be held from 1 - 4 November 2022 in Biopolis, Singapore.
This four-day scientific conference has assembled prominent Hippo researchers from around the world to discuss the latest insights into how this pathway controls development and disease, and how we can target it therapeutically in order to benefit patients with different diseases, most notably cancers. The Conference will provide a platform for valuable exchanges and a forum to foster new collaborations.
We look forward to welcoming you at the Conference.
Session Topics
The Conference will focus on the role of the Hippo pathway in the following major topics:
|
|
Conference Poster
Important Deadlines
|
Abstract Submission Deadline
Registration & Payment Deadline Conference Period |
1 September 2022
1 October 2022 1 - 4 November 2022 |
Enquiries
Supporters
|
|
|
|
Your corporate logo could impress here as well.
Contact us for support opportunities: hippoconference@imcb.a-star.edu.sg
Contact us for support opportunities: hippoconference@imcb.a-star.edu.sg